16:21 EST Oculis (OCS) files automatic mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OCS:
- Oculis price target raised to $44 from $42 at H.C. Wainwright
- Oculis: Advancing Late-Stage Ophthalmology Pipeline Drives Upside and Supports Buy Rating
- Oculis: Strengthened Balance Sheet and Advancing Late-Stage Pipeline Support Buy Rating and Higher $40 Target Ahead of 2026 Pivotal Readouts
- Oculis Posts 2025 Results, Extends Cash Runway and Advances Late-Stage Ophthalmology Pipeline
- Oculis reports Q4 EPS (CHF 0.42c) vs. (CHF 0.67) last year